Schroder Investment Management Group
GH icon

Schroder Investment Management Group’s Guardant Health GH Stock Holding History

Schroder Investment Management Group’s Portfolio GH Stock Details GH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$32.4M Buy
210,541
+209,735
+26,022% +$22.8M 0.02% 449
2026
Q1 		$69.5K Hold
806
– – ﹤0.01% 1168
2025
Q4 		$81.1K Hold
806
– – ﹤0.01% 1136
2025
Q3 		$50K Buy
+806
New +$43.8K ﹤0.01% 1178
2024
Q4 		– Sell
-36,500
Closed -$835K – 1211
2024
Q3 		$835K Hold
36,500
– – ﹤0.01% 1050
2024
Q2 		$1.05M Hold
36,500
– – ﹤0.01% 1022
2024
Q1 		$753K Hold
36,500
– – ﹤0.01% 1061
2023
Q4 		$987K Buy
+36,500
New +$957K ﹤0.01% 1010
2022
Q4 		– Sell
-35,154
Closed -$1.89M – 1294
2022
Q3 		$1.89M Buy
35,154
+15,647
+80% +$803K ﹤0.01% 951
2022
Q2 		$787K Sell
19,507
-20,274
-51% -$1M ﹤0.01% 1105
2022
Q1 		$2.63M Buy
39,781
+31,465
+378% +$2.15M ﹤0.01% 962
2021
Q4 		$832K Sell
8,316
-2,600
-24% -$269K ﹤0.01% 1061
2021
Q3 		$1.36M Sell
10,916
-1,798
-14% -$214K ﹤0.01% 1047
2021
Q2 		$1.58M Buy
12,714
+896
+8% +$121K ﹤0.01% 1061
2021
Q1 		$1.8M Buy
11,818
+6,551
+124% +$990K ﹤0.01% 1032
2020
Q4 		$679K Buy
5,267
+3,158
+150% +$363K ﹤0.01% 1162
2020
Q3 		$228K Buy
2,109
+716
+51% +$65.5K ﹤0.01% 1174
2020
Q2 		$113K Buy
1,393
+553
+66% +$44.6K ﹤0.01% 1148
2020
Q1 		$56K Buy
840
+279
+50% +$21.4K ﹤0.01% 1219
2019
Q4 		$44K Hold
561
– – ﹤0.01% 1241
2019
Q3 		$35K Buy
+561
New +$49.4K ﹤0.01% 1245

Other funds holding GH

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $6.87B AUM 205.24% 1-Year Est. Return

Schroder Investment Management Group's GH Position: Q2 2026 in Review

Schroder Investment Management Group increased its Guardant Health (GH) stake by 26,022% in Q2 2026, buying an estimated $22.8M and bringing the position to 210,541 shares worth $32.4M. The position accounts for 0.02% of the portfolio, ranked #449.

Schroder Investment Management Group first reported a position in GH in Q3 2019 and has held it in 21 quarters since. 597 funds tracked by Wall St. Rank hold GH as of Q2 2026.

  • Schroder Investment Management Group held 210,541 shares of Guardant Health worth $32.4M as of Q2 2026.
  • Schroder Investment Management Group bought 209,735 Guardant Health shares in Q2 2026, an estimated $22.8M.
  • Guardant Health made up 0.02% of Schroder Investment Management Group's portfolio in Q2 2026, its #449 holding.
  • Schroder Investment Management Group first reported a position in Guardant Health in Q3 2019 and has held it in 21 quarters since.
  • 597 funds tracked by Wall St. Rank held Guardant Health as of Q2 2026.

Based on Schroder Investment Management Group's 13F filing for Q2 2026, filed 13 Aug 2026.